期刊文献+

HR-HPV载量与宫颈病变的相关性分析 被引量:32

Correlation analysis of high-risk human papillomavirus viral load and cervical lesions
下载PDF
导出
摘要 目的探讨高危型人乳头瘤病毒(HR-HPV)载量与宫颈上皮内瘤变(CIN)及宫颈癌病变程度的相关性。方法收集解放军总医院2006年1月-2011年8月5年中因宫颈病变行阴道镜活检或手术治疗的1248例患者,根据宫颈病变及临床分期分为5组:宫颈炎组、CINⅠ组、CIN Ⅱ-Ⅲ组、宫颈癌Ⅰ期组、宫颈癌Ⅱ期组,依据第二代杂交捕获实验(HC-Ⅱ)方法检测所有患者HR-HPV病毒载量(RLU/CO),将其分为0~0.99、1.00~9.99、10.00~99.99、100.00~999.99、1000.00~5个HR-HPV病毒载量组。对宫颈炎、CINⅠ、CIN Ⅱ-Ⅲ、宫颈癌Ⅰ期、宫颈癌Ⅱ期各组中不同的HR-HPV病毒载量进行比较,并分析HR-HPV病毒载量与宫颈病变发生的相关性。结果 CINⅠ组、CIN Ⅱ-Ⅲ组、宫颈癌Ⅰ期、宫颈癌Ⅱ期患者HR-HPV病毒载量(分别为842.1±98 3.9、690.1±795.0、893.1±974.2、699.5±908.3RLU/CO)显著高于宫颈炎患者(274.2±613.6,P<0.05);CINⅠ组和宫颈癌Ⅰ期的病毒载量高于CIN Ⅱ-Ⅲ组(P<0.05)。当HR-HPV病毒载量≥100RLU/CO时,CIN及宫颈癌的发生危险度随病毒载量的增加而增加,但HPV病毒载量分级与宫颈病变病理分级无相关性。对于宫颈鳞癌ⅠB-Ⅱ期患者,当HR-HPV病毒载量≥100RLU/CO时,宫颈癌淋巴结转移的危险性增加(P<0.05),且宫颈肿瘤最大直径≥4cm的危险性增加(P<0.05),而HR-HPV病毒载量与患者年龄、组织学类型、宫颈肌层癌浸润深度及淋巴管浸润无关。结论 HR-HPV病毒载量与CIN及宫颈癌的发生密切相关。病毒载量越高,发生CIN及宫颈癌的危险性越大,且与宫颈鳞癌的临床特征有关。 Objective To explore the association between high-risk human papillomavirus (HR-HPV) viral load and pathological grades of cervical intraepithelial neoplasia(CIN) and cervical cancer.Methods A total of 1248 patients from General Hospital of PLA,who underwent colposcopy and surgery due to cervical lesions between Jan.2006 and Aug.2011 were enrolled in this study,and they were divided five groups: cervicitis,CIN Ⅰ,CIN Ⅱ-Ⅲ,stage Ⅰ cervical cancer and stage Ⅱ cervical cancer. HR-HPV viral load (RLU/CO) was determined by the Hybrid Capture Ⅱ (HCⅡ) system, and they were categorized into five groups: 0-0.99,1.00-9.99,10.00-99.99,100.00-999.99,≥1000.00.The mean value and standard deviation of different HR-HPV viral load in the patients with cervicitis or with CIN Ⅰ,CINⅡ-Ⅲ,stage Ⅰ cervical cancer or stage Ⅱ cervical cancer were compared, and the correlation of HR-HPV viral load and pathogenesis of cervical lesions was analyzed. Results HPV viral loads were significantly higher in CINⅠ(842.1±983.9),CINⅡ-Ⅲ(690.1±795.0),stage Ⅰ cervical cancer(893.1±974.2) and stage Ⅱ cervical cancer(699.5±908.3) patients than in cervicitis patients(274.2±613.6,P0.05),and the HPV viral loads in CINⅠ(842.1±983.9) and stage Ⅰ cervical cancer patients were higher than those in CINⅡ-Ⅲ patients(P0.05).When HR-HPV viral load was ≥100RLU/ CO,the risk of CIN and cervical cancer increased with the increase in viral load,but there was no correlation between the viral load and pathological grades of cervical lesions.In the patients with stage ⅠB-Ⅱ cervical squamous cell carcinoma,when the HR-HPV viral load was ≥100RLU/CO,the risk of lymph node metastasis increased(P0.05),and the number of patients with maximum diameter of the cervical tumor ≥4cm also increased(P0.05).However,the HR-HPV viral load was not correlated with patient age,pathological type of the lesion,depth of cancer cell invasion into cervical muscle layer and lymphatic invasion.Conclusions HR-HPV viral load is closely correlated with genesis of CIN and cervical carcinoma.The higher the viral load,the greater the risk of CIN and cervical cancer is,and it is correlated with the clinical features of cervical squamous cell carcinoma.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2012年第5期477-481,共5页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金(30872749)~~
关键词 人乳头瘤病毒 病毒载量 宫颈上皮内瘤样病变 宫颈肿瘤 比值比 human papillomavirus viral load cervical intraepithelial neoplasia uterine cervical neoplasms odds ratio
  • 相关文献

参考文献22

  • 1Correnti M, Medina F, Cavazza ME, et al. Human papillomavirus (HPV) type distribution in cer vical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women[J]. Gynecol Oncol, 2011, 121(3): 527-531.
  • 2Tsai HT, Tsai YM, Yang SF, et al. A notable accessory screening program for detection of cervical intraepithelial neoplasia[J]. Pathol Biol (Paris), 2009, 57(6): 477-482.
  • 3Lorincz AT, Castle PE, Sherman ME, et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer[J]. Lancet, 2002, 360(9328): 228-229.
  • 4De Francesco MA, Gargiulo F, Schreiber C, et al. Detection and genotyping of human papillomavirus in cervical Samples from Italian patients[J]. J Med Virol, 2005, 75(4): 588-592.
  • 5Nielsen A, Kiaer SK, Munk C, et al. Persistence of high-risk human papillomavirus infection in a population-based cohort of Danish women[J]. J Med Virol, 2010, 82(4): 616-623.
  • 6Boulet GA, Horvath CA, Berghmans S, et al. Human papillomavirus in cervical cancer screening: important role as biomarker[J]. Cancer Epidemiol Biomarkers Prev, 2008, 17(4): 810-817.
  • 7Arbyn M, Buntinx F, Van R anst M, et al. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia[J]. J Natl Cancer Inst, 2004, 96(4): 280-293.
  • 8Cox T, Cuzick J. HPV DNA testing in cervical cancer screening: from evidence to policies[J]. Gynecol Oncol, 2006, 103(1): 8-11.
  • 9Ronco G, Segnan N, Giorgi-Rossi P, et al. Human papillomavirus testing and liquid-based cytology in primary cervical screening: results at recruitment from the NTCC randomized controlled trail[J]. J Natl Cancer Inst, 2006, 98(11): 765-774.
  • 10Howard M, Sellors J, Kaczorowski J. Optimizing the hybrid capture II human papillomavirus test to detect cer vical in traepithelial neoplasia[J]. Obstet Gynecol, 2002, 100(5 Pt 1): 972-980.

二级参考文献26

  • 1马正海,张富春,梅新娣,马彩玲,刘开江.新疆维吾尔族妇女宫颈癌组织中HPV16型E6基因突变分析[J].癌症,2004,23(9):1016-1020. 被引量:17
  • 2李庭芳,古力娜.库尔班,古丽沙热,贺国丽,王涛,海日古丽,王振华.新疆伽师县夏普桃勒乡妇女子宫颈癌防治研究[J].新疆医学院学报,1996,19(3):199-203. 被引量:64
  • 3杨英捷,赵健,廖秦平.北京地区人乳头瘤病毒16型感染及其E6/E7基因变异与宫颈病变的相关性研究[J].中华实验和临床病毒学杂志,2007,21(1):32-34. 被引量:15
  • 4Nair P, Jayaprakash PG, Nair MK, et at. Telomerase, p53 and hu man papillomavirus infection in the uterine cervix[J]. Acta Oncol, 2000, 39(1): 65-70.
  • 5Gewin L, Galloway DA. E box-dependent activmion of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc [J]. J Virol, 2001, 75(15): 7198 -7201.
  • 6Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human [J]. Science, 1997, 277(5328) : 955-959.
  • 7zur Hausen H. Papillomaviruses causing cancer: evasion from host cell control in early events in carcinogenesis[J].J Natl cancer Inst, 2000, 92(9): 690- 698.
  • 8Crook T, Tidy JA, Vousden KH. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation [J]. Cell, 1991, 67(3): 547-556.
  • 9Foster SA, Demers GW, Etscheid BG, et al. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest[J]. J Virol, 1994, 68(9): 5698-5705.
  • 10Gao L, Chain B, Sinclair C, et al. Immune response to human papil lomavirus type 16 E6 gene in a live vaccinia vector[J]. J Gen Virol, 1994, 75(Pt 1):157-164.

共引文献7

同被引文献260

引证文献32

二级引证文献145

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部